HIGHRegulatoryTier 1
American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Dental practices that stock Papaverine HCl Injection (used for priapism emergencies or off-label vascular procedures) face a recall of Lot 24072, removing a critical medication from the crash cart and exposing clinics to both patient-safety risk and potential liability if the particulate-laden vials are inadvertently administered.
Key points
- Lot 24072 of 60 mg/2 mL single-dose vials is being pulled nationwide because visible glass particles were detected.
- Recall is at the consumer level, so any dental office that purchased this lot must quarantine stock and return it immediately.
- Papaverine is occasionally kept in oral-surgery or implant suites for managing acute priapism or for intra-arterial vasodilation; loss of this vial could delay emergency response.
- No other lots or sizes of Papaverine HCl Injection are included in this recall, allowing offices to verify stock numbers before re-ordering.
Who should care
OwnerAssociateSpecialist
Read the original on FDA Recalls
Full reporting and any paywall content live on fda.gov. We summarize and score; we do not republish.